Arrowhead Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
17.07.26
/
50%
€64.96
Target price
17.07.27
€83.05
Performance (%)
12.78%
Price
07:30
€73.26
Summary
This prediction is currently active. The prediction currently has a performance of 12.78%. This prediction currently runs until 17.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | -2.471% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (ARWR) had its price target raised by JPMorgan Chase & Co. from $88.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat